Trademarkia Logo

Australia

AU$
Trademark Search
GENE REWRITING

View On IPO.GOV.AU

GENE REWRITING
Cancelled: Cancelled at the request of IB

Last updated on 12 Mar 2025

Owner Info

Tessera Therapeutics, Inc.

200 Sidney Street

Cambridge MA 02139, UNITED STATES OF AMERICA

Serial Number

2147424 filed on 17 Nov 2020

Correspondent

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.

600 Atlantic Avenue,

Boston MA 02210-2206,

UNITED STATES OF AMERICA

GENE REWRITING

Classification Information

Class [005]
Pharmaceutical preparations, therapeutic agents, and pharmaceutical products for gene therapy and DNA editing.

Class [042]
Development of new technology for others for enabling the engineering and modification of DNA, namely, developing molecular and cellular biology reage Read More

Mark Details

Serial Number

2147424

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)

Date

18 May 2020

Mark Type

US

Legal History

Show more

Status DateAction Taken
12th Mar 2025Status change to Voided
4th May 2023Amendment to Amend Owner Requested
19th Apr 2023International Registration in Australia Refused correspondence sent
18th Apr 2023Status change to Lapsed/Not Protected
8th Mar 2023Extension of Time Granted correspondence sent
8th Mar 2023Extension of Time Granted
2th Mar 2023Extension of Time Requested
9th Jan 2023Extension of Time Granted correspondence sent
9th Jan 2023Extension of Time Granted
23rd Dec 2022Extension of Time Requested